Gene expression profiling as a diagnostic tool in acute myeloid leukemia

American Journal of PharmacoGenomics

Volumn 4, Issue 4, 2004, Pages 225-237

  Kern, Wolfgang ^a   Kohlmann, Alexander ^a   Schnittger, Susanne ^a   Hiddemann, Wolfgang ^a   Schoch, Claudia ^a   Haferlach, Torsten ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; CYTOCHEMISTRY; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; DNA MICROARRAY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; HUMAN; IMMUNOPHENOTYPING; POLYMERASE CHAIN REACTION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ACUTE DISEASE; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, MYELOID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 4344570695     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200404040-00002     Document Type: Review

References (54)

1. Haferlach T, Schoch C. Modern techniques in leukemia diagnosis. Internist 2002; 43: 1190-202
2. Fenaux P, Le Deley MC, Castaigne S, et al. Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia: results of a multicenter randomized trial. European APL 91 Group. Blood 1993; 82: 3241-9
3. Kantarjian H, Sawyers C, Hochhaus A, et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002: 346: 645-52
4. Grimwade D, Haferlach T. Gene-expression profiling in acute myeloid leukemia. N Engl J Med 2004 Apr 15; 350: 1676-8
5. Southern E, Mir K, Shchepinov M. Molecular interactions on microarrays. Nat Genet 1999; 21: 5-9
6. Lockhart DJ, Dong H, Byrne MC, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996; 14: 1675-80
7. Holloway AJ, van Laar RK, Tothill RW, et al. Options available -from start to finish -for obtaining data from DNA microarrays II. Nat Genet 2002; 32 Suppl.: 481-9
8. febit Ag. Febit automated genomies [online]. Available from URL: http://www.febit.de [Accessed 2004 Jun 25]
9. Affymetrix homepage [online]. Available from URL: http://www.affymetrix. com [Accessed 2004 Jun 25]
10. Liu WM, Mei R, Di X, et al. Analysis of high density expression microarrays with signed-rank call algorithms. Bioinformatics 2002; 18: 1593-9
11. Lipshutz RJ, Fodor SP, Gingeras TR, et al. High density synthetic oligonucleotide arrays. Nat Genet 1999; 21: 20-4
12. Quackenbush J. Microarray data normalization and transformation. Nat Genet 2002; 32 Suppl.: 496-501
13. Slonim DK. From patterns to pathways: gene expression data analysis comes of age. Nat Genet 2002; 32 Suppl.: 502-8
14. Hastie T, Tibshirani R, Friedman J. The elements of statistical learning. New York: Springer-Verlag, 2001
15. Vapnik V. Statistical learning theory. New York: Wiley, 1998
16. Furey TS, Cristianini N, Duffy N, et al. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 2000; 16: 906-14
17. Brown MP, Grundy WN, Lin D, et al. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci U S A 2000; 97: 262-7
18. BioConductor: open source software for bioinformatics [online]. Available from URL: http://www.bioconductor.org/ [Accessed 2004 Jun 25]
19. Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998; 95: 14863-8
20. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology: the Gene Ontology Consortium. Nat Genet 2000; 25: 25-9
21. Liu G, Loraine AE, Shigeta R, et al. NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res 2003; 31: 82-6
22. Doniger SW, Salomonis N, Dahlquist KD, et al. MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 2003; 4: R7
23. Dahlquist KD, Salomonis N, Vranizan K, et al. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 2002; 31: 19-20
24. Yeung KY, Ruzzo WL. Principal component analysis for clustering gene expression data. Bioinformatics 2001; 17: 763-74
25. Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001; 29: 365-71
26. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-7
27. Ramaswamy S, Tamayo P, Rifkin R, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 2001; 98: 15149-54
28. Ramaswamy S, Golub TR. DNA microarrays in clinical oncology. J Clin Oncol 2002; 20: 1932-41
29. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-11
30. Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41-7
31. Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133-43
32. Zhan F, Hardin J, Kordsmeier B, et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 2002; 99: 1745-57
33. Moos PJ, Raetz EA, Carlson MA, et al. Identification of gene expression profiles that segregate patients with childhood leukemia. Clin Cancer Res 2002; 8: 3118-30
34. Haferlach T, Kohlmann A, Dugas M, et al. Gene expression profiling is able to reproduce different phenotypes in AML as defined by the FAB classification [abstract 731]. Blood 2002; 100 (11): 195
35. Yagi T, Morimoto A, Eguchi M, et al. Identification of a gene expression signature associated with pediatric AML prognosis. Blood 2003; 102: 1849-56
36. Kern W, Kohlmann A, Wuchter C, et al. Correlation of protein expression and gene expression in acute leukemia. Cytometry 2003; 55B: 29-36
37. Schoch C, Kohlmann A, Schnittger S, et al. Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci U S A 2002; 99: 10008-13
38. Debernardi S, Lillington DM, Chaplin T, et al. Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events. Genes Chromosomes Cancer 2003; 37: 149-58
39. Kohlmann A, Schoch C, Schnittger S, et al. Molecular characterization of acute leukemias by use of microarray technology. Genes Chromosomes Cancer 2003; 37: 396-405
40. Virtaneva K, Wright FA, Tanner SM, et al. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A 2001; 98: 1124-9
41. Schnittger S, Kohlmann A, Dugas M, et al. Acute myeloid leukemia (AML) with FLT3-length mutations (FLT3-LM) can be discriminated from AML without FLT3-LM in distinct AML-subtypes based on specific gene expression profiles [abstract 1203]. Blood 2002; 100 (11): 311a
42. Schnittger S, Kohlmann A, Haferlach T, et al. Acute myeloid leukemia (AML) with partial tandem duplication of the MLL-gene (MLL-PTD) can be discriminated from MLL-translocations based on specific gene expression profiles [abstract 1202]. Blood 2002; 100 (11): 310a
43. Neben K, Schnittger S, Wrobel G, et al. Acute myeloid leukemia with normal karyotype and mutation of the FLT3 or MLL gene are characterized by specific gene expression profiles [abstract 2172]. Blood 2002; 100 (11): 553a
44. Schmitz N, Kohlmann A, Schoch C, et al. Gene expression profiling in acute promyelocytic leukemia (APL) with t(15;17): microarray analyses and validation of important genes using real time PCR [abstract 1208]. Blood 2002; 100 (11): 312
45. Haferlach T, Schoch C, Schnittger S, et al. Distinct genetic patterns can be identified in acute monoblastic and acute monocytic leukaemia (FAB AML M5a and M5b): a study of 124 patients. Br J Haematol 2002; 118: 426-31
46. Haferlach T, Schnittger S, Kohlmann A, et al. Genetic profiling in acute monoblastic versus acute monocytic leukemia: a gene expression study on 22 patients [abstract 734]. Blood 2002; 100 (11): 195
47. Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001
48. Kohlmann A, Dugas M, Schoch C, et al. Gene expression profiles of distinct AML subtypes in comparison to normal bone marrow. Blood 2001; 98 (11): 91a
49. Kohlmann A, Dugas M, Schoch C, et al. Gene expression profiles of distinct cytogenetic AML subtypes as defined by the new WHO classification: a study of 45 patients. Oncogenomics 2002: Dissecting Cancer through Genome Research; 2002 May 1, Dublin
50. Schoch C, Kern W, Kohlmann A, et al. AML with complex aberrant karyotype can be distinguished from all other AML subtypes by gene expression profiles and are characterized by higher expression of genes involved in DNA repair [abstract 1204]. Blood 2002; 100 (11): 311a
51. Kohlmann A, Schoch C, Dugas M, et al. A gene expression study of 59 acute myeloid leukemia (AML) patients with recurrent cytogenetic abnormalities [abstract 1205]. Blood 2002; 100: 311a
52. Schnittger S, Schoch C, Dugas M, et al. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood 2002; 100: 59-66
53. Qian Z, Fernald AA, Godley LA, et al. Expression profiling of CD34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. Proc Natl Acad Sci U S A 2002; 99: 14925-30
54. Staudt LM. Molecular diagnosis of the hematologic cancers. N Engl J Med 2003; 348: 1777-85